Similar articles

• [Cardiovascular effects of N-ethyl perhexiline maleate in animals].

  Meng HP, Zhang BH. Meng HP, et al. Yao Xue Xue Bao. 1985 Jun;20(6):401-4. Yao Xue Xue Bao. 1985. PMID: 4096229 Chinese. No abstract available.
• Cardiovascular pharmacology of perhexiline.

  Hudak WJ, Lewis RE, Kuhn WL. Hudak WJ, et al. J Pharmacol Exp Ther. 1970 Jun;173(2):371-82. J Pharmacol Exp Ther. 1970. PMID: 4988496 No abstract available.
• Systemic and coronary hemodynamic effects of perhexiline.

  Rowe GG, Spring DA, Afonso S. Rowe GG, et al. Arch Int Pharmacodyn Ther. 1970 Oct;187(2):377-93. Arch Int Pharmacodyn Ther. 1970. PMID: 4921275 No abstract available.
• [Physiology of coronary circulation as the basis for the evaluation of coronary dilator agents].

  Lochner W. Lochner W. Arzneimittelforschung. 1970 Mar;20:424-32. Arzneimittelforschung. 1970. PMID: 4989252 Review. German. No abstract available.
• [Cardiovascular effects of glucagon].

  Lavarenne J. Lavarenne J. Therapie. 1974 Mar-Apr;29(2):161-84. Therapie. 1974. PMID: 4368071 Review. French. No abstract available.